NAITRE (PreNAtal Care in deprIvaTed enviRonnEment)

November 18, 2020 updated by: Centre Hospitalier Universitaire Dijon

Impact of Conditional Financial Support on Pregnancy Outcomes in Pregnant Women With Low Incomes: Pragmatic Randomized Cluster Trial, With Parallel Arms

This study aims to evaluate the impact of financial support on improving the management of prenatal care in pregnant women with low incomes. The judgment criterion is clinically pertinent: complications of pregnancy. This study also aims to evaluate attitudes to this approach through a qualitative survey.

It is planned to include 4000 women distributed into two arms of 2000 each. One group will receive financial support (prepaid payment card credited for each consultation attended according to the scheduled follow-up as recommended by the Haute Autorité de Santé); the other group will not. The management of the pregnancy for both groups will not be modified.

Study Overview

Study Type

Interventional

Enrollment (Actual)

3787

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Besancon, France, 25030
        • CHRU De Besancon
      • Brest, France, 29609
        • CHRU de Brest
      • Dijon, France, 21079
        • CHU de DIJON
      • Kremlin-bicetre, France, 94270
        • APHP maternité Kremlin Bicêtre
      • Lille, France, 59037
        • Chru de Lille
      • Marseille, France, 13015
        • APHM Hopital Nord
      • Paris, France, 75018
        • APHP Hopital Robert Debré
      • Saint Etienne, France, 42055
        • Chu Saint Etienne
      • Tours, France, 37044
        • CHU Tours

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women
  • Age > 18 years
  • 1st consultation before the 26th week of amenorrhea
  • Recipient of free health care (Couverture Maladie Universelle, Couverture Maladie Universelle-Complémentaire)
  • Who have provided written informed consent to take part in the study

Exclusion Criteria:

  • Persons without national health insurance cover
  • Persons unable to understand the information on the study, despite the help of a translator or a person of trust if necessary
  • Persons under guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group Intervention: Financial support
Delivery of a prepaid payment card credited according to consultations attended
For a sub-group of 40 womens
Active Comparator: Group Control: no financial support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Occurence of complication(s) of pregnancy, wether maternal, fetal or neonatal
Time Frame: Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neonatal morbidity, mortality and rate of transfer of the newborn to a neonatal care unit.
Time Frame: Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
A composite outcome measure consisting of multiple measures: neonatal morbidity, mortality and rate of tranfer of the newborn to a neonatal care unit
Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal morbidity, mortality and rate of caesarean sections
Time Frame: Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
A composite outcome measure consisting of multiple measures: maternal mobidity, mortality and rate og caesarean sections
Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Number of scheduled consultations attended in agreement with the minimal follow-up recommendations of the Haute Autorité de Santé
Time Frame: Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Interview with a sociologist to evaluate perception of the intervention and evaluation of its perceived impact in follow-up of the pregnancy
Time Frame: About 6 weeks after delivery
About 6 weeks after delivery
Differential cost-effectiveness ratio associated with the financial support compared with the absence of support and expressed in terms of cost per complication avoided
Time Frame: Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.
Participants will be followed for the duration of hospital stay and for a maximum of one month after the term date.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 7, 2016

Primary Completion (Actual)

September 9, 2020

Study Completion (Actual)

September 9, 2020

Study Registration Dates

First Submitted

March 17, 2015

First Submitted That Met QC Criteria

March 25, 2015

First Posted (Estimate)

March 30, 2015

Study Record Updates

Last Update Posted (Actual)

November 20, 2020

Last Update Submitted That Met QC Criteria

November 18, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on No intervention

Subscribe